ArticleJTO clinical and research reports2026
Long-Term Response and Survival in Extensive-Stage SCLC Receiving Atezolizumab Plus Chemotherapy in a Real-World Setting: IFCT-1905 CLINATEZO.
Lionel Falchero et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.